Who invested in Avistone Pharmaceuticals?
Avistone Pharmaceuticals's investors include IDG Capital, Vivo Capital and Cathay Capital.
Who invested in Avistone Pharmaceuticals
Funding summaryUpdated 26 Oct 2026
$141Mraised across 1 round since 2023, from 1 source
- Latest round
- Series B, $141MDec 2023
- Investors
- 3
The rounds
- Dec 2023
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Avistone Pharmaceuticals
How much has Avistone Pharmaceuticals raised?
Avistone Pharmaceuticals has raised $141M across 1 round since 2023.
When did Avistone Pharmaceuticals last raise?
Avistone Pharmaceuticals's most recent round was a Series B of $141M in Dec 2023.
What was Avistone Pharmaceuticals's biggest round?
Its most recent round, $141M in Dec 2023, is also its largest on record.
Who backed Avistone Pharmaceuticals first?
Avistone Pharmaceuticals's first round on record, in Dec 2023, was backed by IDG Capital, Vivo Capital and Cathay Capital.
What stage is Avistone Pharmaceuticals at?
Avistone Pharmaceuticals's latest named round is a Series B, in Dec 2023.
Companies like Avistone Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.